[Reduction of the size of the acute myocardial infarct (AMI). Possibilities and limitations. Current status of the problem].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001243:Assisted Circulation; D002994:Clofibrate / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004206:Disopyramide / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use; D007423:Intra-Aortic Balloon Pumping; D008353:Mannitol / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000628:therapy*; D010102:Oxygen Inhalation Therapy; D011465:Prostaglandins, Synthetic / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D004071:Digitalis Glycosides; D011465:Prostaglandins, Synthetic; D013566:Sympathomimetics; D008353:Mannitol; D006493:Heparin; D006821:Hyaluronoglucosaminidase; D004206:Disopyramide; D002994:Clofibrate
Reducerea mărimii infarctului miocardic acut (IMA). Posibilităţi şi limite. Stadiul actual al problemei.